• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by Xylo Technologies Ltd.

    8/22/25 7:28:03 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care
    Get the next $XYLO alert in real time by email
    POS AM 1 ea0254308-posam1_xylotech.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3

    As filed with the Securities and Exchange Commission on August 22, 2025

    Registration No. 333-271984

     

     

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    POST-EFFECTIVE AMENDMENT NO. 1

    TO

    FORM F-3

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    XYLO TECHNOLOGIES LTD.

    (Exact name of registrant as specified in its charter)

     

    Israel   Not Applicable

    (State or Other Jurisdiction of

    Incorporation or Organization)

     

    (I.R.S. Employer

    Identification Number)

     

    10 HaNechoshet St.
    Tel Aviv 6971072, Israel
    (Address of Principal Executive Offices) (Zip Code)

     

    Puglisi & Associates

    850 Library Avenue, Suite 204,

    Newark, DE, 19711, USA

    (Name and address of agent for service)

     

    +1 (303) 738-6680

     (Telephone number, including area code, of agent for service)

     

    Copies to:

     

    Shachar Hadar

    Meitar | Law Offices

    16 Abba Hillel Silver Rd.

    Ramat Gan 5250608, Israel

    Tel: +972-3-610-3100

    Fax: +972-3-610-3111

     

    Approximate date of commencement of proposed sale to the public: Not applicable.

     

    If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

     

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933. 

     

    Emerging growth company ☐    

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

    † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

     

     

     

     

     

     

    DEREGISTRATION OF UNSOLD SECURITIES

     

    This Post-Effective Amendment is being filed by Xylo Technologies Ltd., a company organized under the laws of the State of Israel (the “Registrant”), to withdraw from registration all unsold American Depositary Shares (“ADSs”), each of which represents 40 ordinary shares, no par value, of the Registrant (“Ordinary Shares”), Ordinary Shares, warrants to purchase ADSs, subscription rights and/or units (the “Securities”) that were registered on the Registration Statement on Form F-3 (File No. 333-271984) (the “Registration Statement”), as amended, filed by the Registrant with the Securities and Exchange Commission on May 16, 2023, pertaining to registration of up to $30,000,000 in the aggregate of Securities .

     

    On June 22, 2025, the District Court of Tel Aviv (Economic Division) approved an arrangement (the “Arrangement”) pursuant to Section 350 of the Israeli Companies Law, 5759-1999, between the Company and its shareholders. The Arrangement, which was previously approved by the Company’s shareholders, provides for the acquisition by L.I.A. Pure Capital Ltd. (the “Applicant”) of all issued and outstanding share capital of the Company not already owned by the Applicant. Pursuant to the Arrangement, on or about the date hereof, the Applicant completed, or will complete, the purchase of all of the issued and outstanding share capital of the Company, with the Company becoming a wholly owned subsidiary of the Applicant.

     

    In connection with the closing of the Arrangement, the offerings of the Securities pursuant to the Registration Statement have been terminated. Accordingly, the Registrant hereby terminates the effectiveness of the Registration Statement, and in accordance with undertakings made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that had been registered but remained unsold at the termination of the offerings, hereby removes from registration any and all securities registered but unsold under the Registration Statement as of the date hereof.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this Post-Effective Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Tel Aviv, Israel, on this 22nd day of August, 2025.

     

      Xylo Technologies Ltd.
         
      By: /s/ Tali Dinar 
        Name: Tali Dinar
        Title: Chief Financial Officer

     

    No other person is required to sign this Post-Effective Amendment to the Registration Statement in reliance upon Rule 478 of the Securities Act of 1933, as amended.

     

    2

     

    Get the next $XYLO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XYLO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XYLO
    SEC Filings

    View All

    SEC Form 15-12G filed by Xylo Technologies Ltd.

    15-12G - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/22/25 4:00:04 PM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Xylo Technologies Ltd.

    25-NSE - XYLO TECHNOLOGIES LTD (0001618500) (Subject)

    8/22/25 9:06:32 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Xylo Technologies Ltd.

    POS AM - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/22/25 7:28:03 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    $XYLO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq

    TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Viewbix Inc. (NASDAQ:VBIX), a global developer of ad-tech innovative technologies, has received approval for its shares of common stock to be listed on the Nasdaq Capital Market. Viewbix, in which Xylo holds an indirect stake through its 45.74% ownership in Gix Internet Ltd. ("Gix Internet"), which in turn owns 2,818,585 common shares representing 42.58% of Viewbix, expects its shares to commence trading on Nasdaq under the symbol "VBIX" on or about June 5, 2025, subject to continued

    6/5/25 9:21:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Charging Robotics Successfully Installs Wireless EV Charging System in Automatic Parking Facility

    TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation (62.22% owned by Xylo), has successfully installed a system for wireless charging of electric vehicles with a leading supplier of robotic parking facilities.  Following the installation, the system successfully demonstrated the ability to wirelessly transfer power.  The system is intended to be used for charging electric vehicles ("EVs") while reporting charge data to the cloud and managing the charging

    4/30/25 9:12:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment

    TEL AVIV, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (62.22% owned by Xylo), has secured its first institutional client for the PORTO EV, Revoltz's flagship electric micro-vehicle designed for last-mile logistics. The new order marks a significant step in Revoltz's commercial expansion strategy, transitioning from individual sales into larger fleet deployments. The institutional cus

    4/29/25 6:34:08 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care